JP2007051077A - 変形性関節症の予防及び治療用組成物 - Google Patents
変形性関節症の予防及び治療用組成物 Download PDFInfo
- Publication number
- JP2007051077A JP2007051077A JP2005236242A JP2005236242A JP2007051077A JP 2007051077 A JP2007051077 A JP 2007051077A JP 2005236242 A JP2005236242 A JP 2005236242A JP 2005236242 A JP2005236242 A JP 2005236242A JP 2007051077 A JP2007051077 A JP 2007051077A
- Authority
- JP
- Japan
- Prior art keywords
- chondroitin sulfate
- composition
- collagen
- osteoarthritis
- hyaluronic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 17
- 201000008482 osteoarthritis Diseases 0.000 title claims abstract description 17
- 230000002265 prevention Effects 0.000 title claims abstract description 10
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 claims abstract description 22
- 229920001287 Chondroitin sulfate Polymers 0.000 claims abstract description 22
- 229940059329 chondroitin sulfate Drugs 0.000 claims abstract description 22
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims abstract description 16
- 102000000503 Collagen Type II Human genes 0.000 claims abstract description 16
- 108010041390 Collagen Type II Proteins 0.000 claims abstract description 16
- 210000000845 cartilage Anatomy 0.000 claims abstract description 16
- 229920002674 hyaluronan Polymers 0.000 claims abstract description 16
- 229960003160 hyaluronic acid Drugs 0.000 claims abstract description 16
- 241000972773 Aulopiformes Species 0.000 claims description 14
- 235000019515 salmon Nutrition 0.000 claims description 14
- 239000004480 active ingredient Substances 0.000 claims description 4
- 230000000694 effects Effects 0.000 abstract description 5
- 241000251730 Chondrichthyes Species 0.000 abstract 1
- 230000011164 ossification Effects 0.000 description 7
- 239000002775 capsule Substances 0.000 description 6
- 239000008280 blood Substances 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 210000000988 bone and bone Anatomy 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 208000006386 Bone Resorption Diseases 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- 230000024279 bone resorption Effects 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 238000001914 filtration Methods 0.000 description 3
- 210000002997 osteoclast Anatomy 0.000 description 3
- 208000006820 Arthralgia Diseases 0.000 description 2
- 208000008035 Back Pain Diseases 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- 229920001218 Pullulan Polymers 0.000 description 2
- 239000004373 Pullulan Substances 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 235000019423 pullulan Nutrition 0.000 description 2
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 230000037182 bone density Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 108010049937 collagen type I trimeric cross-linked peptide Proteins 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000004042 decolorization Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000005238 degreasing Methods 0.000 description 1
- 238000004332 deodorization Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 210000004394 hip joint Anatomy 0.000 description 1
- 208000012285 hip pain Diseases 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 208000024765 knee pain Diseases 0.000 description 1
- 230000009245 menopause Effects 0.000 description 1
- 210000002184 nasal cartilage Anatomy 0.000 description 1
- 210000000963 osteoblast Anatomy 0.000 description 1
- 230000001599 osteoclastic effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- -1 sucrose fatty acid ester Chemical class 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
Abstract
【解決手段】コンドロイチン硫酸と、ヒアルロン酸と、II型コラーゲンとを有効成分として含有する。前記コンドロイチン硫酸、ヒアルロン酸、II型コラーゲンは、サケ軟骨から抽出された複合体である。前記コンドロイチン硫酸、ヒアルロン酸、II型コラーゲンを合わせて1日当たり10mg〜5gの範囲で摂取できるように製剤されている。
【選択図】 なし
Description
Claims (3)
- コンドロイチン硫酸と、ヒアルロン酸と、II型コラーゲンとを有効成分として含有することを特徴とする変形性関節症の予防及び治療用組成物。
- 前記コンドロイチン硫酸、ヒアルロン酸、II型コラーゲンは、サケ軟骨から抽出された複合体であることを特徴とする請求項1記載の変形性関節症の予防及び治療用組成物。
- 前記コンドロイチン硫酸、ヒアルロン酸、II型コラーゲンを合わせて1日当たり10mg〜5gの範囲で摂取できるように製剤されたことを特徴とする請求項1または請求項2記載の変形性関節症の予防及び治療用組成物。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2005236242A JP4875865B2 (ja) | 2005-08-17 | 2005-08-17 | 変形性関節症の予防及び治療用NTx値低減剤 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2005236242A JP4875865B2 (ja) | 2005-08-17 | 2005-08-17 | 変形性関節症の予防及び治療用NTx値低減剤 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2008264309A Division JP2009051849A (ja) | 2008-10-10 | 2008-10-10 | 変形性関節症の予防及び治療用組成物 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2007051077A true JP2007051077A (ja) | 2007-03-01 |
JP4875865B2 JP4875865B2 (ja) | 2012-02-15 |
Family
ID=37915776
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2005236242A Active JP4875865B2 (ja) | 2005-08-17 | 2005-08-17 | 変形性関節症の予防及び治療用NTx値低減剤 |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP4875865B2 (ja) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2281265A1 (es) * | 2005-11-24 | 2007-09-16 | Bioiberica, S.A. | Composiciones para el tratamiento de la artrosis. |
JP2009257842A (ja) * | 2008-04-14 | 2009-11-05 | Ttc:Kk | 変形性関節症の検査方法及び診断用キット |
WO2010013498A1 (ja) | 2008-08-01 | 2010-02-04 | 学校法人聖マリアンナ医科大学 | 変形性関節症治療剤又は予防剤 |
WO2011093083A1 (ja) | 2010-01-29 | 2011-08-04 | Axis株式会社 | 変形性関節症治療又は予防用医薬組成物及びその製造方法 |
WO2011093082A1 (ja) | 2010-01-29 | 2011-08-04 | Axis株式会社 | 変形性関節症治療剤または予防剤を製造するための使用 |
WO2011093081A1 (ja) | 2010-01-29 | 2011-08-04 | Axis株式会社 | 変形性関節症治療剤を含有する注射剤 |
CN108159015A (zh) * | 2018-01-09 | 2018-06-15 | 成都通德药业有限公司 | 一种硫酸软骨素钠胶囊及其制备方法 |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6162787A (en) * | 1999-04-02 | 2000-12-19 | Immudyne, Inc. | Methods for treating arthritis using collagen type II, glucosamine chondroitin sulfate, and compositions |
US20020173484A1 (en) * | 2001-05-18 | 2002-11-21 | Harry Leneau | Ingestion of hyaluronic acid for improved joint function and health |
JP2003155250A (ja) * | 2001-11-15 | 2003-05-27 | Fancl Corp | 関節痛を緩和する目的の健康食品 |
JP2003246740A (ja) * | 1995-10-30 | 2003-09-02 | Lab Aeterna Inc | 鮫軟骨エキス |
JP2004149736A (ja) * | 2002-11-01 | 2004-05-27 | Nippon Barrier Free:Kk | コンドロイチン硫酸Na,コンドロイチン硫酸含有物及びそれらの製造方法 |
WO2004083257A1 (ja) * | 2003-03-20 | 2004-09-30 | Hosokawa Micron Corporation | 軟骨魚類から単離されたプロテオグリカンおよびその製造方法 |
JP2005515181A (ja) * | 2001-11-13 | 2005-05-26 | アルコン,インコーポレイティド | 骨関節症を治療するための、ヒアルロン酸ナトリウムとコンドロイチン硫酸との混合物の使用 |
-
2005
- 2005-08-17 JP JP2005236242A patent/JP4875865B2/ja active Active
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2003246740A (ja) * | 1995-10-30 | 2003-09-02 | Lab Aeterna Inc | 鮫軟骨エキス |
US6162787A (en) * | 1999-04-02 | 2000-12-19 | Immudyne, Inc. | Methods for treating arthritis using collagen type II, glucosamine chondroitin sulfate, and compositions |
US20020173484A1 (en) * | 2001-05-18 | 2002-11-21 | Harry Leneau | Ingestion of hyaluronic acid for improved joint function and health |
JP2005515181A (ja) * | 2001-11-13 | 2005-05-26 | アルコン,インコーポレイティド | 骨関節症を治療するための、ヒアルロン酸ナトリウムとコンドロイチン硫酸との混合物の使用 |
JP2003155250A (ja) * | 2001-11-15 | 2003-05-27 | Fancl Corp | 関節痛を緩和する目的の健康食品 |
JP2004149736A (ja) * | 2002-11-01 | 2004-05-27 | Nippon Barrier Free:Kk | コンドロイチン硫酸Na,コンドロイチン硫酸含有物及びそれらの製造方法 |
WO2004083257A1 (ja) * | 2003-03-20 | 2004-09-30 | Hosokawa Micron Corporation | 軟骨魚類から単離されたプロテオグリカンおよびその製造方法 |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2281265A1 (es) * | 2005-11-24 | 2007-09-16 | Bioiberica, S.A. | Composiciones para el tratamiento de la artrosis. |
JP2009257842A (ja) * | 2008-04-14 | 2009-11-05 | Ttc:Kk | 変形性関節症の検査方法及び診断用キット |
WO2010013498A1 (ja) | 2008-08-01 | 2010-02-04 | 学校法人聖マリアンナ医科大学 | 変形性関節症治療剤又は予防剤 |
WO2011093083A1 (ja) | 2010-01-29 | 2011-08-04 | Axis株式会社 | 変形性関節症治療又は予防用医薬組成物及びその製造方法 |
WO2011093082A1 (ja) | 2010-01-29 | 2011-08-04 | Axis株式会社 | 変形性関節症治療剤または予防剤を製造するための使用 |
WO2011093081A1 (ja) | 2010-01-29 | 2011-08-04 | Axis株式会社 | 変形性関節症治療剤を含有する注射剤 |
US9200077B2 (en) | 2010-01-29 | 2015-12-01 | Axis, Inc. | Injectable solution containing therapeutic agent for osteoarthritis |
CN108159015A (zh) * | 2018-01-09 | 2018-06-15 | 成都通德药业有限公司 | 一种硫酸软骨素钠胶囊及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
JP4875865B2 (ja) | 2012-02-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4875865B2 (ja) | 変形性関節症の予防及び治療用NTx値低減剤 | |
CA2069450C (fr) | Procede de fabrication d'un materiau pour osteoplastie a partir d'un tissu osseux naturel et materiau obtenu par ce procede | |
KR20080114717A (ko) | 골다공증의 치료를 위한 gsk-3 억제제 | |
TW200848064A (en) | Process for producing osteocalcin-containing extract | |
JP2009051849A (ja) | 変形性関節症の予防及び治療用組成物 | |
WO2009144578A2 (fr) | Composition synergique osteogenique | |
JP2013063940A (ja) | 骨粗鬆症予防または改善剤 | |
WO2022042541A1 (zh) | 眼镜蛇蛇毒或其提取物在制备降尿酸和/或抗痛风性关节炎的药物中的应用 | |
JP2008056667A (ja) | 上皮病変を治療するためのヒアルロン酸の塩を基とする組成物 | |
FR2604360A1 (fr) | Medicament a liberation controlee pour fournir des ions fluorure | |
EP2162491A1 (fr) | Compositions liquides ou pateuses destinees a l'apport en elements essentiels a la synthese et a la constitution des proteoglycanes, notamment pour le traitement de la degradation du cartilage | |
LU82013A1 (fr) | Nouvelles poudres lyophilisees contenant un sel de l'acide thiazolidine-4-carboxylique et leur procede de preparation | |
JP5426844B2 (ja) | 生体コラーゲン合成促進剤 | |
EP1372731A2 (en) | Polydimethylsiloxane preparation for nail, cartilage, bone and joint disorders | |
JP2008037770A (ja) | 抗加齢剤 | |
CN103110609A (zh) | 一种治疗口腔溃疡的涂膜剂及其制备方法 | |
JPH02218610A (ja) | 骨疾患の予防および治療剤 | |
KR20220027842A (ko) | 해양 이매패류의 껍데기의 유기광물층에 함유된 분자를 단리하는 방법 | |
CN1814282A (zh) | 生物胶原蛋白口服液及其制备方法 | |
FR2784031A1 (fr) | Utilisation de derives de l'acide bisphosphonique pour la preparation d'un medicament destine au traitement des boiteries | |
CA2065572C (fr) | Nouvelles compositions dietetiques a base de lipides complexes phosphores et leur utilisation dans les troubles du sommeil | |
JP2003192599A (ja) | 早漏および/または性的刺激過敏症の予防及び治療用組成物 | |
US11090365B2 (en) | Composition and methods for treating bone and joint disease including extract from crocodilos reptilia and herbs | |
RU2803692C1 (ru) | Способ лечения рецессии десны с применением десневой ткани и препарата стимулятора регенерации | |
JP2006328016A (ja) | 肌荒れ治療用または予防用組成物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20070404 |
|
A871 | Explanation of circumstances concerning accelerated examination |
Free format text: JAPANESE INTERMEDIATE CODE: A871 Effective date: 20071213 |
|
A975 | Report on accelerated examination |
Free format text: JAPANESE INTERMEDIATE CODE: A971005 Effective date: 20080110 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20080213 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20080812 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20081010 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20081117 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20081117 |
|
A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20081218 |
|
A912 | Re-examination (zenchi) completed and case transferred to appeal board |
Free format text: JAPANESE INTERMEDIATE CODE: A912 Effective date: 20090703 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20110525 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20110526 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20110922 |
|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20111128 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20141202 Year of fee payment: 3 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 4875865 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |